Ergebnis der Suchanfrage nach @suche@@suche@d&amp

Helmholtz Munich

SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues

Bosch Healthcare Solutions GmbH

Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Norgine GmbH

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

nova-Institut GmbH

6

Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025

Accord Healthcare

Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®

London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...

Hellmann Worldwide Logistics

Hellmann: Martin Habisreitinger appointed COO Airfreight

Helmholtz Munich

Maria-Elena Torres-Padilla Honored With the Leibniz Prize 2025

Hellmann Worldwide Logistics

3

Hellmann helps supports voluntary engagement

Helmholtz Munich

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

Technische Universität München

New method for designing artificial proteins

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Designing large new proteins with AI New method for designing artificial proteins - Efficient design of new proteins with desired properties - Size of newly designed proteins is approaching that of antibodies - Predicted protein structures successfully validated in experiments Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or ...

Hellmann Worldwide Logistics

2

Hellmann advances innovation with AI-RobotX MEA and Geekplus to enhance eCommerce fulfillment operations

nova-Institut GmbH

6

Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award

Lamilux Heinrich Strunz GmbH

LAMILUX AntiBac Wins “Best Food Safety Innovation of the Decade” at the Gulfood Manufacturing Awards 2024

Lamilux Heinrich Strunz GmbH

5

LAMILUX renovation solutions: Customised, cost-effective and energy-efficient!

Hellmann Worldwide Logistics

2

Hellmann launches next growth phase with new global leadership structure

nova-Institut GmbH

5

Advanced Recycling Conference 2024 – Driving Innovation in Sustainable Materials Management

Hellmann Worldwide Logistics

2

Hellmann: Enrico Farneti appointed Managing Director of Hellmann Italy

Rohde & Schwarz

Rohde & Schwarz technology group closes fiscal year successfully in dynamic market environment

Munich (ots) - Rohde & Schwarz has closed the 2023/2024 fiscal year successfully in a market environment that remains highly dynamic. The company again achieved year-on-year increases in both revenue and incoming orders. With its three divisions Test & Measurement, Technology Systems and Networks & Cybersecurity, the group addressed the current challenges. The ...

Öko-Institut e.V.

New study highlights misalignment of gas infrastructure planning and decarbonisation goals

Joint press release by Oeko-Institut and RAP Berlin, 30. October 2024 New study highlights misalignment of gas infrastructure planning and decarbonisation goals Reforming the regulation of gas distribution systems will be crucial to aligning future energy demand with decarbonisation goals and protecting consumers, concludes a new study by Oeko Institut and the ...

LAUDA DR. R. WOBSER GMBH & CO. KG

Dr. Marc Stricker with LAUDA for ten years

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Stein Hanel GmbH

First fashion label for urns and gravestones launches in the United Kingdom

Helmholtz Munich

Extreme Rainfall Poses Health Risks

Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...